INTRODUCTION
It is estimated 66.8 million people worldwide have glaucoma, most of whom are associated with abnormally high intraocular pressure (IOP) (> 20 mmHg) [1] . The most common way to treat glaucoma is using eye drops, which either reduce the generation of aqueous humor, or help the eye drain out fluid. Usually, this kind of medication needs patients to take the eye drop regularly every morning and evening, making it inconvenient and easily forgotten. On the other hand, some patients may get refractory responses or become allergic to the eye drops. In 1907, Rollet first proposed the idea of implanting a horse-hair thread subconjuctivally trying to drain out the excess eye fluid. Subsequently, other people tried many different kinds of materials [2] . These previous hollow tubes didn't get too much success because of bio-incompatibility and migration of the implants. In addition, the hollow tube, with neither threshold pressure constraint nor high-pressure protecting mechanism, causes excess fluid to leak out of the eye, which leads to hypotony. Thus, it is desirable to have a passive device to regulate the IOP to be below 20 mmHg, along with a protecting mechanism saving the eye from unexpected high pressure (e.g. >50 mmHg). This paper presents the first integrated parylene-tube-type microvalved glaucoma drainage device (GDD) incorporating microflow control system, parylene-tube carrier and anchors, which is designed to fit in a needleimplantable form factor for suture-less minimally invasive implantation through subconjunctival needle injection.
It is well known that a successful GDD must have continuous and reliable IOP control capability. In recent works, we have demonstrated that such requirements can be achieved by using dual checkvalves with flow regulation in required ranges compatible with IOP regulation specification [3] . However, their integration with appropriate surgical components for fixation is also necessary for its practical applications. After proving the concept of using the surgical features in the proposed device in MicroTAS07 [4] and demonstrating the preliminary assembly in HiltonHeadO8 [5] , we have optimized the fabrication and packaging of a new device to create a parylene-tube GDD that targets subconjunctival implantation with needle-inserted and suture-less surgical procedures (Figure 1 ). To accommodate two microvalves, hollow tubes made of thick parylene are utilized and the length is chosen as 6 mm long (Figure 3 ). Both ends of these parylene tube carriers are slanted at 30 degrees to facilitate the surgical implantation and guard the GDD against iris retraction. To prevent the implanted GDD from dislodging, rollable/foldable anchors with hemispherical recesses are also designed. The anchor has a wingspan larger than the O.D. of 19-gauge hypodermic needles and can stretch out after needle retraction for robust fixation. The radius of hemispherical recesses is 300 ptm, fitting and covering the parylene tube O.D. well during later assembly. Every parts of the GDD, (microvalves, parylene tube carriers, parylene anchors), is fabricated separately and finally integrated into one system. The fluid can flow from NC valve to NO valve before the pressure reaches the limit of NO valve, while the opposite direction is forbidden due to the closed NC valve.
lid Figure 3 : Full GDD system consisting of a dual-valve micro-flow regulation system, a parylene-tube carrier, and a rollable/foldable anchor.
FABRICATION AND PACKAGING
The microvalve fabrication started with backside DRIE to leave a 50-ptm-thick membrane ( Figure 4 -(a)).
The circular boundary of the valve seats were also defined here with diameter to be 500 ptm, which can be fit into parylene carrier I.D. smoothly. XeF2 was used to roughen the front side surface to improve the adhesion between parylene and the silicon valve seat. Lithography, which defines the valves' height difference was then performed and done by a 3-step exposure. After parylene coating, RIE was used to pattern coated parylene and then through holes were opened by backside DRIE. The wanted stiction parts of the circumferential of NC valve bonded to silicon surface simultaneously after the sacrificial photoresist were stripped and dried. Tiny epoxy drops were then applied onto these NC valves' stiction-bonding parts to make sure the parylene won't de-laminate after several repeated operations. The fabrication results of microvalves are shown in Figure 5 -(a)-(c).
As for the fixation parts of the system, oxide was first patterned for later XeF2 etching ( Figure 4-(b) ). Figure 5 -(f). Parylene tube carrier was made by coating 35 ptm thick parylene onto glass tubing with 530 ptm in O.D., which were then cut into desired lengths of 6 mm with slanted ends on both sides and later free-released in BHF (Figure 4-(c) ). Result of fabricated parylene tube carrier is shown in Figure 5 -(d).
(a) To package the entire GDD system, one NC valve and one NO valve were released and then inserted into either ends of the parylene tube carrier. The gap between the microvalves' seats and the tube carrier inner wall was sealed by epoxy ( Figure 5-(e) ). To mount the finished valved tube onto parylene fixation anchors, tiny epoxy drops was first wiped on the semi sphere recess. Then, the valved tube was assembled onto the recess. Figure 5 -(g) shows the final assembled GDD with different anchor shapes. Since the O.D. of the parylene tube carrier is 600 ptm (530 ptm + 70 ptm parylene coating), it fixes the fixation anchor nicely after assembled. The anchor is so flexible that it can be rolled/folded and insert into the testing Teflon tube thereafter ( figure 5-(h) ). required pre-stress force to create the cracking pressure. Fluid in single NO valve flows smoothly before pressure reaches the high limit. The flow rate starts to decrease when the pressure goes up to 0.5 psi (-25 mmHg) and almost closes after 1.0 psi (-50 mmHg). The leak rate is less than 5 pt/min. This result proves that the sealing trench designed on NO valve does seal the NO valve opening. The small amount of leak rate may come from the non-flat bottom under the sealing trench which comes from the top surface of the sacrificial photoresist layer. For the dual valve GDD testing, the NC valve successfully opens at 0.33 psi (-17 mmHg) and NO valve starts to function at 1.1 psi (-57 mmHg). The reason that off pressure of NO valve in dual valve system is larger than single valve systems is that part of the energy of the flowing fluid is consumed before NO valve by friction and tether deformation of the NC valve so that only some energy is left to push the NO valve membrane to close the valve. This off pressure delay makes the off pressure of the dual valve system just meet our design requirement to close after 50 mmHg. The reported aqueous formation rate is 2-3 tL/min [6] , which is satisfied perfectly by our GDD. 
BENCH TOP TESTING AND DISCUSSION
To test the completed GDD, one wingspan was folded by tweezers and inserted into Teflon FET tubing, which has I.D. of 750 ptm. The gap between the GDD and the Teflon tubing was sealed with photoresist and dryied in the air (Figure 6 ). Water was chosen as the working fluid to mimic the anterior chamber environment. The Teflon tubing was connected to a pressure gauge with resolution up to 0.01 psi (-5 mmHg). The working fluid was pushed by air, which is regulated by a pressure regulator connected between the air source and pressure gauge. Marching speed of the working fluid advancement inside the Teflon tube was measured so that the flow rate can be calculated by knowing the fluid flow speed and the diameter of the Teflon tubing.
Both NC and NO valves were tested separately and the full GDD was then characterized with experimental verification that its behavior meets the standard IOP regulation requirements (Figure 7 ). The single NC valve starts to pop open at 0.2-0.3 psi (10-15 mmHg), and no obvious flow rate is observed before the cracking pressure. This result meets our simulation expectation and provides the evidence that stiction does provide the Before every GDD is sent to animal surgical testing, the devices are prepared and tested first. After testing is done, the functional GDD is released by soaking into acetone again to ensure functionality of the device. The device wingspan is also stretched back to its original shape after pulling the GDD out of the testing Teflon tubing. The working device is then sent to be sterilized in order to prepare it for later in vivo functionality verification. In A pressure-bandpass configuration is characterized by on bench verification which illustrates that the results meet medical requirements to treat glaucoma patients. It also shows that the epoxy and photoresist sealing during the packaging and testing procedures secure the system from water leakage very well. In terms of the cracking pressure of the NC valve, it can be trimmed, depending on the surgical requirements, by changing the number of tethers, length of tethers, parylene thickness, and sacrificial photoresist height. 
